Early-stage prostate surgery may not benefit patients | Dorian, Goldstein, Wisniewski & Orchinik, P.C.
Dorian, Goldstein, Wisniewski & Orchinik
No Recovery, No Fee for Personal Injury 215-809-3882

Early-stage prostate surgery may not benefit patients

When Pennsylvania men are diagnosed with early-stage prostate cancer, surgery may be one of the treatment options they may have available. However, the results of a 20-year study shows that surgery does not offer major benefits to those who are in the early stage of the disease. In fact, the surgery often results in serious medical complications, including urinary incontinence and infection.

The study found that of the men who had the prostate cancer surgery, 61 percent died due to other causes while 66 percent of those who did not have the surgery died. This number was not significantly different. Approximately 70 percent of men who are newly diagnosed with prostate cancer are found to be in the early stages. This means that the cancer has not progressed beyond the prostate gland and the tumors are non-aggressive. These patients generally have a positive prognosis even if they do get the prostate surgery.

Prostate cancer is the second most common cancer found in American men. It is also the third-leading cause of cancer deaths. It is estimated that more than 161,000 men will be diagnosed with the cancer in 2017 and about 26,700 will die as a result.

When a patient is given unneeded treatment, he or she is put at risk for additional medical complications that could range from infections to a worsened medical condition. If a doctor or surgeon suggests unneeded treatment or fails to warn the patient about potential risks and side effects, the patient could potentially have the grounds to file a medical malpractice lawsuit. An attorney may utilize expert witness testimony and other evidence to prove that the treatment was given in error and that a competent doctor would not have provided the unneeded treatment.

No Comments

Leave a comment
Comment Information